| Identification | Back Directory | [Name]
Elobixibat | [CAS]
439087-18-0 | [Synonyms]
A 3309
AJG-533)
AZD-7806
Elobixibat
Elobixibat
(A-3309
Elobixibat (AZD-7806)
XFLQIRAKKLNXRQ-UUWRZZSWSA-N
L-Phencynonate Hydrochloride
Glycine, (2R)-N-[2-[[3,3-dibutyl-2,3,4,5-tetrahydro-7-(methylthio)-1,1-dioxido-5-phenyl-1,5-benzothiazepin-8-yl]oxy]acetyl]-2-phenylglycyl- | [Molecular Formula]
C36H45N3O7S2 | [MDL Number]
MFCD28386301 | [MOL File]
439087-18-0.mol | [Molecular Weight]
695.89 |
| Chemical Properties | Back Directory | [Boiling point ]
969.6±65.0 °C(Predicted) | [density ]
1.31±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [form ]
Solid | [pka]
3.20±0.10(Predicted) | [color ]
White to off-white | [InChIKey]
XFLQIRAKKLNXRQ-UUWRZZSWSA-N | [SMILES]
C(O)(=O)CNC(=O)[C@@H](C1=CC=CC=C1)NC(COC1C=C2S(=O)(=O)CC(CCCC)(CCCC)CN(C3=CC=CC=C3)C2=CC=1SC)=O |
| Hazard Information | Back Directory | [Uses]
Elobixibat, is an ileal sodium-dependent bile acid transporter ( IBAT) inhibitor, used for the treatment of chronic constipation and irritable bowel syndrome with constipation (IBS-C). |
|
| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Website: |
www.spiropharma.com.cn |
|